Report Categories
View AllRecent Articles
View All
Nrk Q1 2026 Earnings Nuveen Ny Amt Free Muni Fund Posts 0.88 Eps No Ests 20260403 1
USIO Usio Inc shares rise 5 percent on 3 percent year over year Q4 2025 revenue growth despite steep EPS miss
Fulcrum Therapeutics FULC narrows Q1 loss 18 more than expected despite zero revenue shares rise 2
What Construction Partners ROAD segment performance reveals Q1 2026 EPS Exceeds Expectations
Is Streamex STEX stock gaining momentum Smart Money Exits 20260420
SCWO 374Water shares rise 255 percent despite wider than expected Q3 2025 loss and sharp year over year revenue drop
Is KennedyWilson Holdings KW stock risky Q4 2025 EPS Tops Views
Cytokinetics CYTK Stock Soft Quote 008 20260420
Consumer Prices Surge 38 in April Marking Highest Inflation Since May 2023
Apollo Micro Systems Stock Surges Over 5 After Strong Q4 Results Rebounds 70 in Under Two Months
Kevin Warshs Preferred Inflation Measure Draws Caution from Bank of America Economist
Silver Weakness Accelerates as Bearish Wave Structure Unfolds
Chinas Crypto Crackdown Faces Persistent Evasion by Middlemen Court Cases Show
Viatris Analyst Report Highlights Generic Drug Portfolio and Market Position
Trumps 3711 Trades Suggest Complex Automated Portfolio Strategies
OpenAIs IPO Plans Could Mark RecordBreaking Stock Market Debut
Tokenization Could Reshape Credit Markets and Challenge Traditional Banks Says Strategys Michael Saylor
Bessent Predicts Substantial Disinflation as Warsh Assumes Fed Leadership
PagerDuty Q1 2026 Earnings EPS Beat Surprises Stock Holds Flat
TEM Q1 2026 Earnings EPS Beats Estimates by 328 Amidst Revenue Data Gap
AEON Biopharma Q4 2025 Earnings Major EPS Miss and No Revenue Weigh on Investor Sentiment
PSEC Q1 2026 Earnings EPS Misses Estimates as Investment Income Falls Short
XNCR Q1 2026 Earnings Earnings Miss by Wide Margin as Losses Deepen
LMND Q1 2026 Earnings Narrowing Losses Beat Expectations as Underwriting Improves
Tenaya Therapeutics TNYA Edges Higher Biotech Stock Tests Key Resistance at 084
eXoZymes Inc EXOZ Climbs 313 as Biotech Stock Tests Key Resistance at 1074
OptimizeRx Holds Steady at 494 as Traders Await a Catalyst
Salesforce CRM Edges Higher as Investors Eye Cloud Growth and Key Resistance
Talon Capital Corp Warrants TLNCW Decline 25 as Selling Pressure Mounts
External Links
AutoZone Shares Fall After Quarterly Revenue Miss
RILYL Q1 2024 Earnings Preferred Stock Reports Negative EPS Amid Market Challenges
Digital Realty Trust DLR Holds Near Resistance as Modest Decline Tests Momentum
Mizuho Maintains Outperform Rating on ON Semiconductor Raises Price Target on AI Tailwinds
Fed Chair Powell Vows No Shadow Chair Role But Clash with Kevin Warsh May Be Inevitable
A O Smith Analyst Coverage Market Expectations and Rating Trends
Bureau of Prisons AI Contract Signals Technology Shift in Correctional Management
Ferraris Electric Car Luce Faces Online Backlash Shares Slide Nearly 8
Consumer Credit Growth Surges in December Signaling Strong Consumer Spending
Bessent Highlights Substantial Disinflation Outlook as Warsh Assumes Fed Leadership